⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL29023715 | 0.91 | GABBR2 (0.48) | — | |
| Phosphoric Acid SCHEMBL29023714 | 0.91 | GABBR2 (0.48) | — | |
| SCHEMBL7028928 | 0.85 | TP53 (0.43) | — | |
| SCHEMBL14955034 | 0.83 | TP53 (0.42) | — | |
| SCHEMBL11305169 | 0.81 | TP53 (0.45) | — | |
| Sulfuric Acid SCHEMBL10353223 | 0.79 | TP53 (0.58) | — | |
| SCHEMBL27275677 | 0.79 | — | — | |
| SCHEMBL777190 | 0.79 | — | — | |
| SCHEMBL29100255 | 0.78 | GABRR1 (0.38) | — | |
| SCHEMBL6946803 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159605-A1 | HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT | ABION INC. (KR) | 2023-05-25 | — | — | US | claimed |
| EP-4144748-A1 | HUMAN INTERFERON-BETA VARIANT WITH DOUBLE MUTATION AND METHOD FOR IMPROVING STABILITY OF HUMAN INTERFERON-BETA VARIANT | Abion Inc. (KR) | 2023-03-08 | — | — | EP | claimed |
| CN-106104268-B | Lithium reagent composition uses the lithium ion measuring method and measurement device for having the composition | 梅托珍尼克斯株式会社 | 2019-06-07 | — | — | CN | claimed |
| CN-107602809-A | High-solid content water-based polyurethane dispersion liquid a kind of while based on aminocarboxylate and sulfamate | 温州大学 | 2018-01-19 | — | — | CN | claimed |
| CN-106814121-A | A kind of serum sugar spectrum classifying method based on micro-fluidic chip | 中国科学院大连化学物理研究所 | 2017-06-09 | — | — | CN | claimed |
| CN-102994612-A | Liquid monomer reagent for determining content of ammonia in blood serum, preparation method and application thereof | BEIJING LEADMAN BIOCHEMISTRY CO LTD | 2013-03-27 | — | — | CN | claimed |
| CN-102507957-A | Method and kit for determining apolipoprotein A2 by using immunity transmission turbidimetric method | BEIJING LEADMAN BIOCHEMISTRY CO LTD | 2012-06-20 | — | — | CN | claimed |
| CN-101617045-A | Removal of molecular analysis interferents of nucleic acids using buffered solutions of chaotropic agents | SIERRA MOLECULAR CORP | 2009-12-30 | — | — | CN | claimed |
| CN-101406706-A | Microcapsular ultrasound contrast agent based on surfactant and preparation method thereof | HARBIN INST OF TECHNOLOGY (CN) | 2009-04-15 | — | — | CN | claimed |
| CN-101290287-A | Reduction type coenzyme and its derivates regeneration technology and uses thereof | BEIJING LEADMAN BIOCHEMISTRY T (CN) | 2008-10-22 | — | — | CN | claimed |
| CN-101128604-A | Methods for performing direct enzymatic reactions involving nucleic acid molecules | BIOQUEST INC (KR) | 2008-02-20 | — | — | CN | claimed |
| EP-0188450-A4 | METHODS FOR THE IN VITRO DETECTION AND IDENTIFICATION OF UNKNOWN PATHOGENS OR GENETIC ENTITIES. | DIAGNOSTIC RES LTD (US) | 1989-02-02 | — | — | EP | claimed |
| EP-0188450-A1 | METHODS FOR THE IN VITRO DETECTION AND IDENTIFICATION OF UNKNOWN PATHOGENS OR GENETIC ENTITIES. | DIAGNOSTIC RESEARCH LIMITED PA (US) | 1986-07-30 | — | — | EP | claimed |
| WO-1986000139-A1 | METHODS FOR THE IN VITRO DETECTION AND IDENTIFICATION OF UNKNOWN PATHOGENS OR GENETIC ENTITIES | DIAGNOSTIC RESEARCH LIMITED PARTNERSHIP (US) | 1986-01-03 | — | — | WO | claimed |
| CN-116546990-B | CD73 inhibitor and pharmaceutical application thereof | RISEN (SUZHOU) PHARMA TECH Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4587446-A1 | BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2025-07-23 | — | — | EP | disclosed |
| EP-4561639-A2 | COMPOSITIONS AND METHODS FOR GENOME EDITING | Celyntra Therapeutics SA (BE) | 2025-06-04 | — | — | EP | disclosed |
| WO-1986000139-A1 | METHODS FOR THE IN VITRO DETECTION AND IDENTIFICATION OF UNKNOWN PATHOGENS OR GENETIC ENTITIES | DIAGNOSTIC RESEARCH LIMITED PARTNERSHIP (US) | 1986-01-03 | — | — | WO | disclosed |
| EP-0122552-A2 | Aqueous polyurethane compositions containing a cross-linker, and their use in thermo-active one-layer transfer coating | BAYER AG (DE) | 1984-10-24 | — | — | EP | disclosed |
| US-4379872-A | Amphoteric amino sulfonate derivatives of epoxy resins | NIPPON PAINT CO., LTD. (JP) | 1983-04-12 | — | — | US | disclosed |